Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
ASP 6537
Known as:
ASP-6537
, ASP6537
National Institutes of Health
Create Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Additive antithrombotic effect of ASP6537, a selective cyclooxygenase (COX)‐1 inhibitor, in combination with clopidogrel in guinea pigs
C. Sakata
,
K. Suzuki
,
Y. Morita
,
T. Kawasaki
European journal of pharmacology
2017
Corpus ID: 8584462
ABSTRACT Clopidogrel (Plavix®, Sanofi‐Aventis), the adenosine diphosphate P2Y12 receptor antagonist, is reported to be effective…
Expand
2017
2017
Inhibitory effects of ASP6537, a selective cyclooxygenase-1 inhibitor, on thrombosis and neointima formation in rats.
C. Sakata
,
T. Kawasaki
,
Y. Iwatsuki
,
Yumiko Moritani
,
Y. Morita
,
H. Hara
Thrombosis research
2017
Corpus ID: 41026450
INTRODUCTION Percutaneous coronary interventions (PCIs), such as balloon angioplasty and stent placement, are effective in the…
Expand
2013
2013
ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without "aspirin dilemma".
C. Sakata
,
T. Kawasaki
,
+6 authors
M. Okada
Thrombosis research
2013
Corpus ID: 11287223
INTRODUCTION Aspirin inhibits both the cyclooxygenase (COX)-1-dependent production of thromboxane A2 (TXA2) in platelets and COX…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE